These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [ACE inhibitors and early diabetic nephropathy].
    Author: Bangstad HJ, Hartmann A, Berg TJ, Hanssen KF.
    Journal: Tidsskr Nor Laegeforen; 1995 Oct 10; 115(24):3039-41. PubMed ID: 7570536.
    Abstract:
    At present we are able to disclose diabetic nephropathy in the very early stages, i.e. when urinary albumin excretion is only slightly increased (20-200 micrograms/min = microalbuminuria). Good blood glucose control and active antihypertensive treatment may stop or retard the further development towards renal failure. Angiotensin-converting-enzyme (ACE)-inhibitors seem to have a renoprotective effect. In this article we suggest guidelines for the use of ACE-inhibitors in patients with type 1 diabetes and early diabetic nephropathy. Special concerns are included in respect of adolescents, pregnant women and persons with type 2 diabetes.
    [Abstract] [Full Text] [Related] [New Search]